News
The second phase of Mumbai Metro Line 3, also known as the Aqua Line, is nearing its launch. The Commissioner of Metro Rail Safety (CMRS) began inspecting the 9.77-km underground stretch from Bandra ...
YANTAI, China, April 8, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym ...
Currently, Metro Line 3 is functional between Aarey JVLR and BKC, covering 12.69 km since its partial launch on October 7, 2024. The new stretch, phase 2A, between BKC and Worli, once cleared ...
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...
Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer. Enriqueta Felip, MD, PhD, the Universitat ...
With the completion of this second phase, the Metro-3 will officially enter the island city, making travel more convenient for Mumbaikars. This phase will connect key locations such as Dharavi and ...
With an increasing focus on sustainability and technology advances, the new Phase 3 programme will play a pivotal role in further strengthening the state's industrial ecosystem such as green ...
today announced the completion of patient enrollment in its NATiV3 Phase 3 clinical trial with the randomization of the last patient in the main cohort. Inventiva has enrolled 1009 patients in the ...
A New York City drug developer led by well-known executives and backed by some of the top names in biotech investing is shutting down, a … ...
the company’s pivotal Phase 3 trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer, met its primary endpoint of improved progression-free survival ...
Save this article to read it later. Find this story in your account’s ‘Saved for Later’ section. Meghan Markle has taken a lot of flak for her two recent business endeavors: a Netflix ...
the company’s pivotal Phase 3 trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer, met its primary endpoint of improved progression-free survival, as assessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results